Cynthia Fisher

Last updated

Cynthia Fisher (born January 16, 1961) is an American businesswoman, entrepreneur, and corporate board director. She was a pioneer in the stem cell industry, founding the cord blood stem cell banking company, ViaCord, Inc., in 1993. [1] In 2000, she co-founded ViaCell, which went public in 2005 [2] and was subsequently acquired by PerkinElmer for its ViaCord brand. [3]

Contents

Fisher is founder and managing director of WaterRev, LLC, an investment firm focused on companies with novel technologies that enable sustainable practices of water use. [4] She is a director and advisor to publicly-held and private companies and nonprofit organizations. [5]

Career

Fisher began her career at IBM in sales and marketing in 1983. After receiving her MBA in 1990 from Harvard Business School, she joined Haemonetics and was marketing manager of the Blood Bank Division. [6] In 1993, Fisher set up ViaCord, Inc., a company that tests, types, freezes and stores the umbilical cord blood of newborns for its potential use in treating some cancers, blood disorders, and genetic diseases. [7] She served as CEO from ViaCord’s inception until 2000. [8]

In 2000, Fisher co-founded and was president of ViaCell, a cellular medicines company. [9] ViaCord then became a division of ViaCell. ViaCell went public in 2005 at a $260 million valuation. [10] Fisher’s role in the "rearing" of ViaCell was the subject of a Harvard Business School case study. [8] PerkinElmer acquired ViaCell in 2007 for $300 million for its ViaCord business. [3] [11] Fisher served on the Board of Directors of ViaCord and ViaCell. From 2002 to 2004, she was Chair of the Board of the Massachusetts Biotechnology Council. [12]

Since 2000, Fisher has founded, advised, and invested in several privately-held enterprises. She mentors entrepreneurs and is a guest lecturer at several graduate schools of business (Harvard Business School, [8] Brandeis University, [13] Bentley University, and Boston University). [14]

In 2011, she set up WaterRev, LLC, an investment firm focused on companies with novel technologies that enable sustainable practices of water use. Through 2018, Fisher was on the board of Water.org, the nonprofit organization founded by Gary White and Matt Damon.

Fisher became a director in 2012 of The Boston Beer Company, the maker of Samuel Adams Beer, Angry Orchard Cider, and Twisted Tea. [15] [16] She was the first woman on the company's board, but her appointment was criticized because she was married to Jim Koch, the company's founder. [17]

Since 2015, Fisher has been a director of Easterly Government Properties, a real estate investment trust focused on Class A commercial properties leased to U. S. Government agencies. [18] [19]

In 2016, Fisher co-founded FitMoney, Inc., a nonprofit organization providing K-12 curriculum for financial literacy. [20]

In 2017, Fisher was appointed by Speaker of the House Paul Ryan to the Health Information Technology Advisory Committee. [21]

The same year, Fisher set up PatientRightsAdvocate.org, a nonprofit organization that advocates for patients and employers to access price transparency in healthcare, to reduce the cost of care for patients, employers, and the government. [22]

Her commentaries advocating for price discovery have been reported in The Boston Globe , [23] U.S. News & World Report , [24] Issues & Insights, [25] and RealClearHealth. [26]

In 2018, Fisher was appointed to the Board of Directors of the National Park Foundation. [27]

Education

Fisher received an MBA from Harvard Business School. [28] She has a B.S. in Biophysics from Ursinus College, [29] where she was awarded an Honorary Doctorate in Science in 2006. [30]

Personal life

Fisher is married to Jim Koch. [31]

Related Research Articles

<span class="mw-page-title-main">Mass General Brigham</span> Health care system based in Greater Boston, Massachusetts

Mass General Brigham is a not-for-profit, integrated health care system that engages in medical research, teaching, and patient care. It is the largest hospital-based research enterprise in the United States, with annual funding of more than $2 billion. The system's annual revenue was nearly $18 billion in 2022. It is also an educational institution, founded by Brigham and Women's Hospital and Massachusetts General Hospital. The system provides clinical care through two academic hospitals, three specialty hospitals, seven community hospitals, home care services, a health insurance plan, and a robust network of specialty practices, urgent care facilities, and outpatient clinics/surgical centers. It is the largest private employer in Massachusetts. In 2023, the system reported that from 2017–2021 its overall economic impact was $53.4 billion – more than the annual state budget.

<span class="mw-page-title-main">Vertex Pharmaceuticals</span> American pharmaceutical company

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

<span class="mw-page-title-main">PerkinElmer</span> American corporation focused on life science research

PerkinElmer, Inc., previously styled Perkin-Elmer, is an American global corporation that was founded in 1937 and originally focused on precision optics. Over the years it went into and out of several different businesses via acquisitions and divestitures; these included defense products, semiconductors, computer systems, and others. By the 21st century, PerkinElmer was focused in the business areas of diagnostics, life science research, food, environmental and industrial testing. Its capabilities include detection, imaging, informatics, and service. It produced analytical instruments, genetic testing and diagnostic tools, medical imaging components, software, instruments, and consumables for multiple end markets. PerkinElmer was part of the S&P 500 Index and operated in 190 countries.

<span class="mw-page-title-main">Elizabeth Nabel</span> American academic

Elizabeth Nabel is an American cardiologist and Executive Vice President of Strategy at ModeX Therapeutics and OPKO Health. Prior to this role, she served as President of Brigham Health and its Brigham and Women's Hospital, Professor of Medicine at Harvard Medical School, and Director of the NIH's National Heart, Lung, and Blood Institute.

Laurie Hollis Glimcher is an American physician-scientist who was appointed president and CEO of Dana–Farber Cancer Institute in October 2016. She was elected a Member of the American Philosophical Society in 2019. Glimcher has been at the center of controversies related to animal rights activists, excessive corporate payments, and research misconduct.

<span class="mw-page-title-main">Jim Koch</span> American businessman and founder of Boston beer company

Charles James Koch is an American entrepreneur, billionaire, and the co-founder and chairman of the Boston Beer Company, the producers of Samuel Adams beer. Koch is widely considered to be a founding father of the American craft brewing movement.

<span class="mw-page-title-main">Vicki Sato</span> American biologist

Vicki L. Sato is a retired professor of management practice at Harvard Business School and a professor of the practice in the department of molecular and cell biology at Harvard University. Since 2021, she has been a member of the President’s Council of Advisors on Science and Technology (PCAST).

Bill Walczak is a community activist in Boston, Massachusetts, United States. He was a candidate for mayor of Boston in 2013.

<span class="mw-page-title-main">Horizon Discovery</span>

Horizon Discovery Group plc ("Horizon"), is a gene editing company that designs and engineers genetically modified cells and then applies them in research and clinical applications in human health.

<span class="mw-page-title-main">Cryo-Cell International</span>

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Deutsche Knochenmarkspenderdatei, abbreviated as DKMS, is an international nonprofit bone marrow donor center based in Tübingen, Germany, with entities in Chile, India, Poland, South Africa, the United Kingdom and the United States. DKMS works in the areas of blood cancer and hematopoietic stem cell transplantation and raises awareness of the need for donors for hematopoietic stem cell transplantation which people with blood cancers need for treatment as well as helping people sign up to their national bone marrow registries. Over the years, DKMS has expanded beyond Germany.

<span class="mw-page-title-main">Henri Termeer</span>

Henri A. Termeer was a Dutch biotechnology executive and entrepreneur who is considered a pioneer in corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme. Termeer created a business model adopted by many others in the biotech industry by garnering steep prices— mainly from insurers and government payers— for therapies for rare genetic disorders known as orphan diseases that mainly affect children. Genzyme uses biological processes to manufacture drugs that are not easily copied by generic-drug makers. The drugs are also protected by orphan drug acts in various countries which provides extensive protection from competition and ensures coverage by publicly funded insurers. As CEO of Genzyme from 1981 to 2011, he developed corporate strategies for growth including optimizing institutional embeddedness nurturing vast networks of influential groups and clusters: doctors, private equity, patient-groups, insurance, healthcare umbrella organizations, state and local government, and alumni. Termeer was "connected to 311 board members in 17 different organizations across 20 different industries" He has the legacy of being the "longest-serving CEO in the biotechnology industry.

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

The Institute for Clinical and Economic Review (ICER) is a Boston-based independent nonprofit organization that seeks to place a value on medical care by providing comprehensive clinical and cost-effectiveness analyses of treatments, tests, and procedures.

<span class="mw-page-title-main">Jeffrey Leiden</span> CEO of biotechnology company

Jeffrey Leiden is an American businessman who is the executive chairman of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts. He was initially appointed to the board of directors of the company in 2009 and was CEO and president from February 2012 to March 2020.

bluebird bio, Inc., based in Somerville, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders.

BioBridge Global is a San Antonio-based nonprofit holding company that operates the South Texas Blood & Tissue Center, QualTex Laboratories, GenCure, and The Blood and Tissue Center Foundation. BioBridge Global supplies products and services in blood resource management, cellular therapy, donated umbilical cord blood and human tissue, and testing of blood, plasma, and tissue. The organization was initially established as the South Texas Regional Blood Bank in 1973.

<span class="mw-page-title-main">Cynthia E. Dunbar</span> American hematologist

Cynthia Dunbar is an American scientist and hematologist at the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH). She is the Branch Chief of the Translational Stem Cell Biology Branch.

<span class="mw-page-title-main">Revvity</span> American biotech company

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.

Joan Toland Bok (née Toland) is an energy executive and lawyer who served as the chairwoman of New England Electric System between 1984 and 1998. She was the first woman to lead a large American energy company. She also served as director of the Avery Dennison Corporation.

References

  1. ↑ Fisher keeps blazing biotech trail in New England
  2. ↑ ViaCell, Inc. Completes Initial Public Offering; Sells All Over-Allotment Shares
  3. 1 2 PerkinElmer to acquire ViaCell in $300m deal
  4. ↑ Water.org Board Member Cynthia Fisher
  5. ↑ Archived 2007-11-18 at the Wayback Machine The Boston Beer Company Directors
  6. ↑ Women Execs Saying Goodbye
  7. ↑ Seizing Nature's Lifeline
  8. 1 2 3 Cynthia Fisher and the Rearing of ViaCell
  9. ↑ Cell Makers
  10. ↑ ViaCell's Costly Mistake
  11. ↑ Healthy Bid for ViaCell
  12. ↑ Balancing Patient Privacy and Innovation–Where do we go from here?
  13. ↑ Archived 2015-09-07 at the Wayback Machine The Asper Center Events, Lectures and Conferences Past Events
  14. ↑ Planning and Operating New Ventures; Course Number: MET AD740
  15. ↑ Archived 2007-06-21 at the Wayback Machine The Boston Beer Company Corporate Governance
  16. ↑ HBS Alum Cynthia Fisher A Valuable Asset on Boston Beer Co. Board of Directors
  17. ↑ Shirley Leung (July 31, 2013). "Boston Beer gives women cold shoulder". The Boston Globe . Retrieved December 13, 2019.
  18. ↑ Easterly Government Properties Inc. Investor Relations
  19. ↑ Easterly Government Properties Inc. Corporate Profile
  20. ↑ "SAM Company Profile & Executives - Boston Beer Co. Cl A - Wall Street Journal". www.wsj.com. Retrieved September 8, 2020.
  21. ↑ Congressional Record vol. 163, no. 125, pg. H6279
  22. ↑ A Powerful Lobbying Tool in the Trump Era: the President’s Ear
  23. ↑ "Imagine a situation where you knew just what your surgery would cost - The Boston Globe". BostonGlobe.com. Retrieved March 26, 2024.
  24. ↑ Fisher, Cynthia (October 22, 2019). "Commentary: Business Roundtable Should Demand Health Care Price Transparency". US News & World Report. Retrieved March 26, 2024.
  25. ↑ Fisher, Cynthia A. (October 29, 2019). "Businesses, Not Politicians Can Lead The American Revolution In Health Care By Demanding Transparent Prices". Issues & Insights. Retrieved March 26, 2024.
  26. ↑ "Price Transparency is More than a Worthwhile Experiment | RealClearHealth". www.realclearhealth.com. Retrieved March 26, 2024.
  27. ↑ National Park Foundation Board of Directors biography
  28. ↑ The Future of Stem Cells
  29. ↑ Nutrient-rich umbilical cord blood preserved as potential aid to immune system
  30. ↑ Innovative Alumni Share Entrepreneurial Expertise
  31. ↑ Business Owners: Do What You Love
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.